Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04053842Phase 2Completed
Phase 2, open-label, single-arm trial. Primary endpoint: Pathologic Validation and Modeling at 4 years. Started Feb 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04053842.